In vitro Competitors binding reports verified that MAM-2201 and AM-2201 have nanomolar affinity for both CD-1 murine and human CB1 and CB2 receptors, with preference for the CB1 receptor. In arrangement Together with the in vitro binding data, in vivo research confirmed that MAM-2201 induces Visible, acoustic, and tactile impairments https://elbertr617ixl1.ktwiki.com/user